IL5 and COVID-19: In parallel, patients with severe COVID-19 showed reduced concentrations of key Th2-related mediators (MDC, IL-5) and likely compensatory production of the anti-inflammatory mediator IL-10 (Fig. 1b, c, Supplementary Table 1).